These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19790032)

  • 1. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea.
    Hellum BH; Tosse A; Hoybakk K; Thomsen M; Rohloff J; Georg Nilsen O
    Planta Med; 2010 Mar; 76(4):331-8. PubMed ID: 19790032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.
    Hellum BH; Nilsen OG
    Basic Clin Pharmacol Toxicol; 2008 May; 102(5):466-75. PubMed ID: 18331390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
    Eagling VA; Profit L; Back DJ
    Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J; Buddha B; Dey S; Pal D; Mitra AK
    Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
    Iwanaga K; Hayashi M; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
    Drug Metab Dispos; 2010 Aug; 38(8):1286-94. PubMed ID: 20463004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro CYP3A4 metabolism: inhibition by Echinacea purpurea and choice of substrate for the evaluation of herbal inhibition.
    Hansen TS; Nilsen OG
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):445-9. PubMed ID: 18947363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
    Elsby R; Surry DD; Smith VN; Gray AJ
    Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.
    Bhardwaj RK; Glaeser H; Becquemont L; Klotz U; Gupta SK; Fromm MF
    J Pharmacol Exp Ther; 2002 Aug; 302(2):645-50. PubMed ID: 12130727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo.
    Li M; de Graaf IA; van de Steeg E; de Jager MH; Groothuis GM
    Toxicol In Vitro; 2017 Apr; 40():26-33. PubMed ID: 27939799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients.
    Engdal S; Nilsen OG
    Phytother Res; 2009 Jul; 23(7):906-12. PubMed ID: 19170155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp.
    Li X; Hu J; Wang B; Sheng L; Liu Z; Yang S; Li Y
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):163-75. PubMed ID: 24380838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of cytochrome P-450 activities and quantification of constituents in a selection of commercial Rhodiola rosea products.
    Thu OK; Nilsen OG; Hellum B
    Pharm Biol; 2016 Dec; 54(12):3249-3256. PubMed ID: 27572116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
    Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides.
    Sergent T; Dupont I; Jassogne C; Ribonnet L; van der Heiden E; Scippo ML; Muller M; McAlister D; Pussemier L; Larondelle Y; Schneider YJ
    Toxicol Lett; 2009 Feb; 184(3):159-68. PubMed ID: 19070657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
    Gutmann H; Poller B; Büter KB; Pfrunder A; Schaffner W; Drewe J
    Planta Med; 2006 Jun; 72(8):685-90. PubMed ID: 16755466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4.
    Achira M; Suzuki H; Ito K; Sugiyama Y
    AAPS PharmSci; 1999; 1(4):E18. PubMed ID: 11741214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assessment of P-glycoprotein inhibition and induction in vitro.
    Perloff MD; Störmer E; von Moltke LL; Greenblatt DJ
    Pharm Res; 2003 Aug; 20(8):1177-83. PubMed ID: 12948015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells.
    Hou XL; Takahashi K; Kinoshita N; Qiu F; Tanaka K; Komatsu K; Takahashi K; Azuma J
    Int J Pharm; 2007 Jun; 337(1-2):169-77. PubMed ID: 17270371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.